Oral tofacitinib: Contemporary appraisal of its role in dermatology
Tofacitinib, an oral Janus kinase inhibitor (Jakinib), is an emerging treatment modality whose well-established efficacy in systemic inflammatory diseases is now being actively explored for cutaneous disorders (arising due to the patient's dysimmune responses) that are not responding to and/or susta...
Sparad:
| Huvudupphov: | , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
Wolters Kluwer Medknow Publications
2019-01-01
|
| Serie: | Indian Dermatology Online Journal |
| Ämnen: | |
| Länkar: | http://www.idoj.in/article.asp?issn=2229-5178;year=2019;volume=10;issue=5;spage=503;epage=518;aulast=Sonthalia |
| Taggar: |
Inga taggar, Lägg till första taggen!
|